Literature DB >> 10328540

Rapid detection and identification of two lineages of influenza B strains with monoclonal antibodies.

N Nakagawa1, A Maeda, T Kase, R Kubota, Y Okuno.   

Abstract

Monoclonal antibodies (Mabs) against influenza B virus were obtained by immunizing mice with B/Nagasaki/1/87, one of the strains of the B/Victoria group. Immunoprecipitation analysis revealed that individual Mabs precipitated the nucleoprotein (NP), the matrix protein (M) or the hemagglutinin protein (HA). By using these Mabs by the peroxidase-antiperoxidase (PAP) staining method, a rapid detection and identification method for influenza B virus was established. Monolayers of Madin-Darby canine kidney cells in microplates were infected with each-strain and incubated for about 24 h, and then were subjected to the PAP staining method using the Mabs as the first antibody. Influenza B virus strains are classified into two major phylogenetic trees, the B/Victoria group and the B/Yamagata group. When anti-NP and anti-M antibodies were used in the PAP staining method, all 13 influenza B virus strains isolated from clinical specimens between 1940 and 1994 were detected regardless of the antigenic drift of the influenza virus. On the other hand, several anti-HA Mabs which reacted specifically with the strains of the B/Victoria group, did not react with any strain of the B/Yamagata group. In the 1996/97 influenza season in Osaka Prefecture in Japan, two antigenically distinct groups of influenza B virus strains were isolated. They belonged to different phylogenetic trees and were clearly distinguishable by the PAP staining method with anti-HA Mabs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10328540     DOI: 10.1016/s0166-0934(99)00015-4

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  9 in total

1.  Variation of the conserved neutralizing epitope in influenza B virus victoria group isolates in Japan.

Authors:  Naoko Nakagawa; Ritsuko Kubota; Yoshinobu Okuno
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

2.  Discovery of the neutralizing epitope common to influenza B virus victoria group isolates in Japan.

Authors:  Naoko Nakagawa; Jun Suzuoki; Ritsuko Kubota; Shinzo Kobatake; Yoshinobu Okuno
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

3.  Heterogeneity of influenza B virus strains in one epidemic season differentiated by monoclonal antibodies and nucleotide sequences.

Authors:  N Nakagawa; R Kubota; A Maeda; T Nakagawa; Y Okuno
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

4.  Influenza B virus victoria group with a new glycosylation site was epidemic in Japan in the 2002-2003 season.

Authors:  Naoko Nakagawa; Ritsuko Kubota; Akiko Maeda; Yoshinobu Okuno
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

5.  Human RNA polymerase I-driven reverse genetics for influenza a virus in canine cells.

Authors:  Pirada Suphaphiphat; Bjoern Keiner; Heidi Trusheim; Stefania Crotta; Annunziata Barbara Tuccino; Pu Zhang; Philip R Dormitzer; Peter W Mason; Michael Franti
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

6.  Emergence of an influenza B virus with antigenic change.

Authors:  Naoko Nakagawa; Souichi Nukuzuma; Shigekazu Haratome; Shosan Go; Toshimasa Nakagawa; Kozaburo Hayashi
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

7.  Three Types of Broadly Reacting Antibodies against Influenza B Viruses Induced by Vaccination with Seasonal Influenza Viruses.

Authors:  Daisuke Hirano; Nobuko Ohshima; Ritsuko Kubota-Koketsu; Ayami Yamasaki; Gene Kurosawa; Yoshinobu Okuno; Shunji Yoshida; Yoshikazu Kurosawa
Journal:  J Immunol Res       Date:  2018-05-08       Impact factor: 4.818

8.  Antiviral Activity and Underlying Action Mechanism of Euglena Extract against Influenza Virus.

Authors:  Ayaka Nakashima; Yuka Horio; Kengo Suzuki; Yuji Isegawa
Journal:  Nutrients       Date:  2021-10-30       Impact factor: 5.717

9.  Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors.

Authors:  Ritsuko Kubota-Koketsu; Hiroyuki Mizuta; Masatoshi Oshita; Shoji Ideno; Mikihiro Yunoki; Motoki Kuhara; Naomasa Yamamoto; Yoshinobu Okuno; Kazuyoshi Ikuta
Journal:  Biochem Biophys Res Commun       Date:  2009-07-04       Impact factor: 3.575

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.